Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern

Mostrar otras versiones (1)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) results in a variety of clinical symptoms ranging from no or mild to severe disease. Currently, there are multiple postulated mechanisms that may push a moderate to severe disease into a critical state. Human serum contains abundant eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffin, Amanda J., O’Donnell, Kyle L., Shifflett, Kyle, Lavik, John-Paul, Russell, Patrick M., Zimmerman, Michelle K., Relich, Ryan F., Marzi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913826/
https://www.ncbi.nlm.nih.gov/pubmed/35273264
http://dx.doi.org/10.1038/s41598-022-07960-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913826/
https://www.ncbi.nlm.nih.gov/pubmed/35273264
http://dx.doi.org/10.1038/s41598-022-07960-4

Ejemplares similares